Key words: fibronectin/type V collagen/cell adhesion/insulin
A variety of endothelial cell growth factors, such as fibroblast growth factors, bind to cell surface heparan sulfate proteoglycans (9) . These interactions of growth factors with extracellular matrix are important in the compartmentalization, storage, stabilization, and modulation of the activities of growth factors. Westudied the interaction of insulin with several extracellular matrix proteins, and reported that type V collagen binds to insulin most strongly (15). The insulin-binding site of type V collagen is in a 30-kDa CNBr fragment of the al(V) chain. This region is rich in basic amino acids, and also binds to heparin (14) . Wedetermined the complete primary structure of the CDNA of humancollagen al(Y) chain, and found that the insulin-and heparinbinding region is located in the N-terminal half of the a\ chain (12) .
Insulin bound to the type V collagen substratum stimulates the DNAsynthesis of mouse mammarytumor MTDcells (15). Type V collagen is therefore expected to be a useful cell adhesion protein for cell culture, because insulin is an important growth factor for a variety of cultured cells. However, many types of cell cannot adhere to type V collagen, and type V collagen even inhibits the adhesion of endothelial cells or flbroblasts to fibronectin (1, 3) . This antiadhesive activity of type V collagen is mainly found in the al(V) chain, but the activity was abolished after treatment of type V collagen
To whomreprint requests and correspondence should be addres- with CNBr (3). We therefore thought that the 30-kDa CNBr fragment of the al(V) chain, which bind to insulin and heparin, has little antiadhesive activity. Kimizuka et al. (6, 7) prepared several recombinant fibronectin fragments that contained the cell binding Arg-Gly-Asp-Ser sequence, and reported that these recombinant fragment had the cell-adhesive activity. One of the active fragments, C277, contains three pieces of type III repeats of fibronectin, and one Arg-Gly-AspSer sequence in the C-terminal part of the peptide (7) . In the present study, we constructed a plasmid encoding the insulin-and heparin-binding region of human al(V) chain, and attempted to make a fusion protein of this peptide with the fibronectin fragment C277. Such a fusion protein is expected to have both cell-adhesive and insulin-binding activities. Here, we report the construction of the fusion gene, its expression in E. coli, purification of the fusion protein, and the insulin-binding and cell-adhesive properties of the purified fusion protein.
MATERIALS AND METHODS

Materials.
Restriction enzymes, cloning vectors M13mpl8, M13MP19, pTV119N, pUC118, andpUC119, isopropyl-/3-D-thio-galactopyranoside (IPTG), and cell-adhesive fibronectin peptide C274, were the products of Takara Shuzo Co. (Kyoto). Aprotinin, leupeptin, phenylmethyl-sulfonyl fluoride (PMSF), ampicilin, bovine crystalline insulin, and bovine serum albumin (BSA, RIA grade) were purchased from Sigma (St. Louis, MO).
Construction ofplasmid. A CDNAfragment that encodes the insulin-binding region of the a\ chain of human type V collagen was amplified by polymerase chain reaction (PCR) on the basis of the previously reported DNAsequence of the al(V) (12) . A template CDNAwas synthesized from 1 jug of human placental mRNA (Clontech) using Rous associated virus-2 reverse transcriptase (Takara Shuzo) (2). The PCRwas done with 100 pmol each of primers:
5'-GATCCCATGGGCATCCGTGGTCTGAAG-3', and
and one-tenth of the synthesized template by the use of a DNAamplification kit (GeneAmpá",Cetus), with 30 repeats a cycle of 0.5 min at 95°C for denaturation, 0.5 min at 55°C for annealing, and 1 min at 72°C for elongation. The amplified fragment had additional Ncol site, stop codon, and BamHl site for cloning and termination of translation.
The fragment was digested with Ncol and BamHI, and then ligated into NcoI-BamUl site of plasmid pTV118N. A DNA fragment was prepared from this plasmid by treatment with Ncol-Hindlll, and ligated with a plasmid pTF7520, which encodes the cell binding domain of human fibronectin (Fig. 1) . The resulting plasmid that encodes the fusion protein of fibronectin and type V collagen was termed pTF7520-Col-V-In. Nucleotide sequence of the plasmid was confirmed by the dideoxy chain termination method (1 1) using suitable cloning vectors with the enzyme Sequenase ver. 2.0 (U.S. Biochemical). Purification of fusion protein. E. coli strain JM109 having the plasmid pTF7520-Col-V-In was grown to late log phase in 100 ml of ampicilin-containing LB medium at 37°C. IPTG (1 mM)was added to the medium and cultivation was continued overnight. The cells were harvested by centrifugation, washed with phosphate buffered saline (PBS), and then disrupted by sonication in 5 ml of lysis buffer (PBS that contained 1 mMEDTA, 0.05% Nonidet P40, lO^g/ml aprotinin, l0jug/m\ leupeptin, and 2 mMPMSF). The extract was centrifuged at 12,000 r.p.m. for 15 min, and 1 ml of the supernatant was put on a HPLCcolumn of Heparin 5PW(Tosoh, Tokyo). After the column was washed with PBS, the bound material was eluted with PBS that contained 0.5 MNaCl at a flow rate of 1 ml/min. Purity of the proteins was tested by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) in 4-20% gradient gels in Laemmli's buffer sys- Roskilde) were coated with C274 or fusion protein at room temperature for 2 hr, and any uncoated surface of the wells were blocked with 2% BSAat 37°C for 2 hr. Cells were trypsinized and suspended in a small amount of DMEM containing 0.5 mg/ml soybean trypsin inhibitor (Sigma), and then diluted with serum-free DMEM. Approximately 105 cells were put in each well, and the wells were incubated at 37°C for 2 hr. The wells were then washed with PBS, and the cells were dispersed by trypsinization. Figure 4 shows the binding of peroxidase-conjugated insulin to the E. coli extract and to purified C277-V on nitrocellulose membranes. As a control, we used the recombinant fibronectin fragment C274, which lacks three amino acid residues of the C-terminus of C277 but has similar cell-adhesive activity as C277 (7).
Insulin-peroxidase bound to a 30-kDa protein present in the extract in the control E. coli strain JM109, which In, that encodes the fusion protein of fibronectin and al(V), was constructed as descibed in Fig. 1 . E. coli strain JM109was transfected with the expression vector and was grown in 100 ml ofLB medium at 37°C. IPTG (1 mM)was added to the medium when the OD600 of the culture was 0.3. Cultivation was continued until the OD600 reached 1.0, and the cells were harvested and then disrupted by sonication. The insoluble materials were removed by centrifugation.
SDS-PAGE analysis of the total cellular extract showed that a new protein component of about 50-kDa was induced by IPTG in JM109-pFT7520-Col-V-In cells (Fig. 2, lane 3) , which was not found in the control E. coli strain JM109 (Fig. 2, lane 1) or in the transfected cells before induction by IPTG (Fig. 2, lane 2) . The size of this component agreed with the calculated molecular weight (48, 160) of the fusion protein (7, 12) . Purification offusion protein. The extract (l ml)
was put on a column of Heparin 5PW. After the column was washed with PBS, the bound materials were eluted by addition of 0.5 M NaCl (Fig. 3A) . The heparin-bound fraction contained one major (50-kDa) and one minor (48-kDa) components (Fig. 3B, lane 3) . did not contain the plasmid (Fig. 4B, lane 1, indicated by an arrow). The nature of this insulin-binding protein produced by E. coli is not known. Insulin-peroxidase bound to the 50-kDa fusion protein in the crude extract of JM109-pTF7520-Col-V-In (lane 2), the a\ chain of type V collagen (lane 3), and the purified fusion protein C277-V (lane 4), but did not bind to the fibronectin fragment C274 (lane 5). As judged from the staining intensity, the insulin-binding activity of C277-V seemed to be similar to that of al(V). The cell-adhesive activity of C277-V was determined using Swiss mouse 3T3 (Fig. 5A ) and mouse melanoma B16-F10 cells (Fig. 5B ). In the both cases, the fusion protein showed cell-adhesive activity, but the concentration required for the half-maximal activity for C277-V was approximately 10-times higher than that of C274.
In the case of 3T3 cells, similar numbers of cells adhered to the dishes and spread well when the dishes were coated with 1 juM of each protein. Subsequent experiments were therefore carried out using 1 juM C277-V. Growth of mouse MTDcells on fusion protein.
Mousemammarytumor MTDcells grow well in serumfree culture mediumwith insulin as the only growth factor supplement (4). We used this cell line to examine the mitogenic activity of substrate-bound insulin. Tissue culture wells were coated with 1 juM C274 or C277-V, respectively, and then blocked with BSA. Insulin (10 jug/ml in PBS) was added to the wells and left at room temperature overnight. Unadsorbedinsulin was then removed by repeated washing with PBS. MTDcells were inoculated into the wells in serum-free mediumwithout insulin, and the growth rate of the cells was determined (Fig. 6) . The cell numbers at day 0 were determined at 4 hr after inoculation. On the C277-V substratum pretreated with 10 /ig/ml insulin, significant stimulation of cellular growth was observed on day 2 (Fig. 6A ), but no such a stimulating effect was observed on C274 (Fig.  6B) . Attachment of the cells to the dishes on day 0 was also enhanced by the pretreatment of the C277-V substratum with insulin, but the cell numbers in the insulintreated dishes began to decrease after day 3. Table I shows the effects of different concentrations of insulin on the growth of MTDcells on the C277-V and C274 substrates. Maximum stimulation of cellular growth was obtained when the C277-Vsubstratum was pretreated with 10 to 100^g/ml insulin. This agreed with the previous results obtained using type V collagen as an adsorbent of insulin (15). MTDcells were cultivated on C274 or C277-V substrates in serum-free mediumthat contained various concentrations of insulin (Fig. 7) . In this experiment, the substrates were not pretreated with insulin. The growth of the cells were stimulated by insulin in a dosedependent manner on the both substrates during the first two days, but the cell number also decreased, on day 4, probably due to the detachment of the cells from the dishes.
DISCUSSION
Fusion protein-C277-V, which contains the cell-binding region of human fibronectin and the heparin-and insulin-binding regions of the al chain of human type V collagen, was expressed in E. coli and purified by heparin affinity chromatography. The collagen region in this fusion protein contained 186 amino acids (amino acid residue 799 to 984 in the a\ chain), which contained a cluster of basic amino acids (12, 14) . The basic amino acids in this region are thought to be important in the interaction of type V collagen with heparin and insulin (14) . The size of the collagen fragment incorporated into the fusion protein was muchsmaller in size than the heparin-and insulin-binding CNBr peptide (30-kDa), which we have previously isolated (14) , but the Concentration (nM) translational modifications are not necessary for these binding activities.
The fusion proten retained cell-adhesive and cellspreading activities of the original fibronectin fragment, but approximately 10-times higher concentration of C277-V was required for the half-maximal cell adhesion as compared with C274. The cell binding RGDSsequence is present in the very C-terminal region of C277, so we suspect that the insertion of another peptide fragment to the C-terminus of C277 might cause some decrease in the cell-adhesive activity by interfering with the interaction of the fusion protein with the cell surface adhesion receptors. Insulin bound to the fusion protein substrates enhanced the adhesion and growth of mouse mammarytumor MTDcells. Larger number of cells usually adhered to the dishes on day 0 when C277-V was pretreated with insulin ( Fig. 6 and Table 1 ). Such stimulation of cell adhesion might be explained by the binding of the cells to substrate-bound insulin by means of insulin receptors on the cell surface. Maximum stimulation of the growth was observed whenthe substrates were coated with 10 to 100 //g/ml insulin. These growth-promoting effects of the fusion protein were comparable with those obtained for native type V collagen as we reported previously (15). Because no such stimulating effect was observed on the C274 substrates, this growth enhancement must be due to the increased affinity of the fusion protein for insulin. The stimulation of growth was most distinct during the first two days of cultivation, but the cell number tended to decrease thereafter. The cell numbers also tended to decrease after prolonged cultivation on the C274 or C277-V substrates even when 1 jug/m\ insulin, which was sufficient to sustain the growth of MTD cells (4, 15) , was added to the culture medium (Fig. 7) . The decrease in the cell numbers therefore seems to be due to the limited cell adhesive activity of the recombi- nant fibronectin molecules, and further improvement of this point would be required. The present results showed that a new biological function could be added to the cell-binding peptide of fibronectin using gene technological methods. Wehave recently found that a fusion protein of fibronectin with epidermal growth factor (EGF) retained the growth enhancing activity of EGF(5). These bifunctional fusion proteins, that have both cell-adhesive and growth enhancing activities, would probably be effective in the concentration of growth factors in the vicinity of cell surfaces or in the stabilization of their activities. The recombinant techniques described here seem to be useful to construct the cell-adhesive proteins that are more advantageous for the proliferation of the cells in culture. Wealso attempt to apply these recombinant proteins for clinical uses such as wound healing.
